08:45-09:00

Welcome address
C. Stefanadis, President of the Symposium

09:00-10:15

Round Table 1: «Special cardiorenal issues»

Chairmen: D. Alexopoulos, K. Siamopoulos

Biomarkers of renal dysfunction. Current data and future perspectives
D.Tousoulis 

Renal function during acute coronary syndromes: The clinical problem, the therapies and the impact on outcomes 
G. Lazaros 

Asymptomatic patient with microalbuminuria and/or increased serum creatinine. How to improve the cardiovascular outcome 
I. Paraskevaidis

Which is the best imaging modality for identification of coronary artery disease in patients on hemodialysis or after renal transplantation?  
Α. Κitsiou 

Comments-Discussion: I. Papadakis, A. Androulakis, I. Redoukas, C. Antonakoudis

10:15-11:45

Round Table 2: Sympathetic nervous system and cardiorenal disease: From the pathophysiology to clinical practice

Chairmen: C. Stefanadis, Ath. Manolis

Renal sympathetic control. Why is it important
P. van de Borne  

Renal denervation: From scientific evidence to clinical application
I. Hofmann

Renal sympathetic denervation: Past, present and future
V. Papademetriou  

Impact of baroreceptor activation on achieving BP control in resistant hypertension
G. Βakris 

Comments-Discussion: Th. Apostolou, D. Papadopoulos, D.Papadogiannis, C. Grassos

11:45-12:15

Coffee Break

12:15-13:30

Debate1: Cardiorenal vs renocardiac vs syndrome

Chaimen: A. Karabinis, J. Lekakis

The cardiological perspective  
C. Tsioufis

The nephrological perspective
D. Vlachakos

Does it really exist?
F. Triposkiadis

Comments-Discussion: C. Stratos, D. Goumenos

13:30-14:45

Round Table 3: Hypertension and chronic renal dysfunction

Chairmen: Ν. Zakopoulos, D. Babalis

Which are the ideal blood pressure levels?
G. Stergiou

Which are the heart rate targets? 
L. Poulimenos

RAS blockade: What to expect?
C. Thomopoulos

Current status of aldosterone receptor antagonists
M. Papavasileiou

Comments-Discussion: A. Pittaras, D. Tsiachris, E. Manios, D. Metzikof

14:45-15:30

Light Lunch

15:30-16:45

Round Table 4: How is pharmacological treatment adjusted in the setting of kidney failure?

Chairmen: M. Anastasiou-Nana, V. Pirgakis

Atrial fibrillation and oral anticoagulants: Does kidney function matters?
D. Richter

Double antiplatelet therapy in chronic kidney disease
K. Toutouzas

Erythropoietin in renal disease: Friend or foe of cardiac function?
J. Parissis

Vitamin D in renal disease: Is it protective to the heart? 
M. Doumas

Comments-Discussion: Α. Spanos, D. Mavrogianni, E. Tsiamis, S. Patsilinakos, T. Chiras

16:45-17:15

Satellite Lecture

Organizer: Boehringer Ingelheim

Chairman: C. Tsioufis

Fixed-dose combinations of rennin-angiotensin-aldosterone system blockers with calcium antagonists: Are all the same?
T. Makris

17:15-17:30

Coffee Break

17:30-18:15

Debate 2: Resistance to diuretic therapy

Chairmen: I. Nanas, P.Toutouzas

The cardiological approach is enough
G. Konstantelos

The nephrological contribution is essential
D. Petras

Comments-Discussion: A.Trikas, M. Sonikian

18:15-19:30

Round Table 5: Managing severe cardiac disease in a patient with renal dysfunction

Chairmen: Ant. Manolis, C. Pitsavos 

Sudden cardiac death: the interventional approach 
Κ. Gatzoulis

Valvular Disease
E. Vavuranakis

Peripheral arterial disease
C. Vlachopoulos

Patient undergoing CABG
I. Chlorogiannis

Comments-Discussion: G. Theodorakis, P. Dilaveris, K. Tentolouris, C. Olympios,
G. Economopoulos, D. Nikas 

19:30

Closing remarks

C. Stefanadis
President of the 4th International Symposium “Cardiovascular Disease and Renal Dysfunction 2012”